← Back to Skills Marketplace

Incyte Corp

Name: Incyte Corp
Author: hanxueyuan

by hanxueyuan · GitHub ↗ · v1.0.0 · MIT-0

cross-platform ✓ Security Clean

Downloads

Stars

Active Installs

Versions

Install in OpenClaw

/install incyte-corp

Description

Incyte Corp specializes in oncology and inflammation biopharmaceuticals, with Jakafi as its leading JAK1/2 inhibitor product for blood cancer and inflammator...

README (SKILL.md)

历史时间线

1991 在特拉华创立
1990s-2000s 建立激酶抑制剂研究平台
2011 Jakafi获批治疗骨髓纤维化
2017 与诺华合作开发CAR-T细胞疗法
2020 Jakafi获批治疗慢性移植物抗宿主病
2023 收入约35亿美元

商业模式

核心收入来自Jakafi（ruxolitinib）——JAK1/2抑制剂。管线聚焦肿瘤学（PD-1/PD-L1组合疗法）和炎症（特应性皮炎）。

护城河分析

Jakafi在骨髓纤维化领域几乎是垄断地位——首个获批的JAK抑制剂。激酶抑制剂平台可扩展到其他靶点。

关键数据

2023年收入约35亿美元
Jakafi年销售额超30亿美元
员工约2,500人
市值约120亿美元

有趣事实

Incyte最初是一家为其他制药公司提供激酶筛选服务的公司——他们建立了全球最大的激酶化合物库之一。

Usage Guidance

This skill appears safe from an agentic-security perspective. Treat its company and market facts as informational reference material and verify them independently if using them for research, medical, or investment decisions.

Capability Analysis

Type: OpenClaw Skill Name: incyte-corp Version: 1.0.0 The skill bundle contains purely informational content regarding Incyte Corp, a biopharmaceutical company. The SKILL.md file provides historical timelines, business analysis, and financial data without any executable code, network requests, or suspicious instructions.

Capability Assessment

✓ Purpose & Capability

The artifact is coherent with the stated purpose: it provides background, timeline, business model, and market facts about Incyte.

✓ Instruction Scope

The SKILL.md content contains informational reference material only and does not instruct the agent to take actions, override goals, use tools, or access user data.

✓ Install Mechanism

There is no install specification, no code files, no required binaries, and no package or script execution.

✓ Credentials

The skill declares no environment variables, credentials, config paths, OS restrictions, or external capabilities.

✓ Persistence & Privilege

No persistence, background operation, privileged access, or local/system mutation is shown in the artifacts.

How to Use

Make sure OpenClaw is installed (local or Docker)
Run the install command in chat: /install incyte-corp
After installation, invoke the skill by name or use /incyte-corp
Provide required inputs per the skill's parameter spec and get structured output

Version History

v1.0.0

Incyte-corp skill initial release: - 提供Incyte公司历史、商业模式、核心产品Jakafi及管线信息 - 包含营收、员工、市值等关键数据（截至2023年） - 总结Jakafi在骨髓纤维化治疗市场的地位与公司竞争优势 - 适用于肿瘤学药物开发、JAK抑制剂市场分析等场景 - 附带公司早期发展趣闻

Metadata

Slug incyte-corp

Version 1.0.0

License MIT-0

All-time Installs 0

Active Installs 0

Total Versions 1

Frequently Asked Questions

What is Incyte Corp?

Incyte Corp specializes in oncology and inflammation biopharmaceuticals, with Jakafi as its leading JAK1/2 inhibitor product for blood cancer and inflammator... It is an AI Agent Skill for Claude Code / OpenClaw, with 30 downloads so far.

How do I install Incyte Corp?

Run "/install incyte-corp" in the OpenClaw or Claude Code chat to install it in one step — no extra setup required.

Is Incyte Corp free?

Yes, Incyte Corp is completely free, licensed under MIT-0. You can download, install and use it at no cost.

Which platforms does Incyte Corp support?

Incyte Corp is cross-platform and runs anywhere OpenClaw / Claude Code is available (cross-platform).

Who created Incyte Corp?

It is built and maintained by hanxueyuan (@hanxueyuan); the current version is v1.0.0.

More Skills